Obesity and type 2 diabetes mellitus (T2DM) are complex chronic diseases with rapidly growing prevalence across the world. Human studies have found that both genetic and environmental factors contribute to T2DM; the clearest lifestyle factors are high caloric intake and low physical activity. The mechanisms by which human T2DM arises is still unclear, but obesity, insulin resistance and ß-cell dysfunction all play a role.
Rodents on a high-fat diet are often used to study human T2DM. As a result, many of the mechanisms of rodent T2DM are known. Translation of the research, however, to human obesity and diabetes is still not possible.
This review evaluates the limits of rodent high-fat diet models of human T2DM. Modifying the diet of rodents appears to have limited applicability to human diabetes for several reasons, including: very different dietary compositions, variability in bacterial species and strains in the gut, and inconsistency of the penetrance, severity, and duration of T2DM.
Authors say the time has come to turn away from rodents and seek to understand human obesity and diabetes by using data specific to humans. They say this would increase our understanding of disease mechanisms and spur the development of new therapeutics.
Paul Enck Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany.
His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions.
He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.